Seqens Seqens

X

Find Radio Compass News for DSSTox_CID_3440

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

Canada

Canada

0

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

https://www.fiercepharma.com/pharma/u-k-supreme-court-rejects-nhs-claim-eu220m-financial-loss-servier-ip-lawsuit

K. Dunleavy FIERCEPHARMA
03 Jul 2021

https://www.europeanpharmaceuticalreview.com/news/136926/class-4-medicines-defect-missing-safety-information-in-some-perindopril-products/

Hannah Balfour EUROPEANPHARMACEUTICALREVIEW
15 Dec 2020

http://www.pharmatimes.com/news/nhs_england_scraps_7_more_drugs_on_prescription_1293506

Anna Smith PHARMATIMES
09 Jul 2019

https://www.moneycontrol.com/news/business/eu-court-upholds-40-mn-euro-fine-on-lupin-over-perindopril-litigation-3284951.html

MONEY CONTROL
11 Dec 2018

https://www.forbes.com/sites/robertglatter/2018/10/27/common-blood-pressure-medication-linked-to-increased-risk-of-lung-cancer/#5cbb12807b4e

Robert Glatter, MD FORBES
27 Oct 2018

http://www.symplmed.com/symplmed_news_january_26_2015/

SYMPLMED
21 Jan 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY